Medpace Holdings, Inc.

NASDAQ:MEDP

Medical - Diagnostics & Research

Healthcare
$646.87 -0.98%

-$4.51 today

Market cap
$18.09B
Beta
1.18
P/E (TTM)
28.2
EPS (TTM)
$16.19
52W Low $301.90High $628.92

Volume 0.21M

Average 0.36M

MEDP Operating Cash Flow

Cash generated by the company's core business operations during the period.

Medpace Holdings, Inc.NASDAQ: MEDP

Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026

Operating cash flow dips below year-ago levels

Q3 FY2026 operating cash flow of $216.6M fell 12.0% year over year, behind the +1.7% change in trailing-twelve-month operating cash flow. Sequentially, it rose 33.7% from the prior quarter. Over 3 fiscal years it compounded at +22.5% a year.

Context

  • Operating cash flow amounted to 28.2% of revenue in FY2025, down 0.7 pp from a year earlier.
  • Operating cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -12.0% toward the trailing-twelve-month pace of +1.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$216.6M+33.7% QoQ
Last fiscal yearDec 2025
$713.22M+17.1% YoY
LTMSep 2026
$723.05M+1.7% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.0%——
1 year+17.1%——
3-year CAGR+22.5%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
713.22M USD
Year-over-year change
+17.1%
4-year CAGR
+28.3%

Operating Cash Flow vs competitors

How MEDP compares with its peers on the latest reported figures

  • MEDP's LTM Sep 2026 operating cash flow of $723.05M is the 3rd largest of the 5 companies compared; the peer median is $1.1B.
  • Its year-over-year change of +1.7% is the 4th highest of 5, against a peer median of +23.0%.
  • Operating cash flow amounts to 25.5% of revenue for MEDP, versus a peer median of 15.6%.
MEDP Competitors Peer median
Operating Cash Flow for MEDP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$2.82B +7.7%+5.5%16.6%
ICLRICON Public Limited CompanyLTM Jun 2026$1.62B +38.4%+22.5%19.6%
MEDPMedpace Holdings, Inc.LTM Sep 2026$723.05M +1.7%+22.5%25.5%
CRLCharles River Laboratories International, Inc.LTM Jun 2026$582.15M -26.1%+6.0%14.6%
FTREFortrea Holdings Inc.LTM Jun 2026$182.4M +308.0%+11.1%6.8%
Peer median (excluding MEDP) $1.1B+23.0%+8.6%15.6%

Competitors are the stored peer set for MEDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income181.85M245.37M282.81M404.39M451.12M
Depreciation & Amortization21.12M22.34M26.33M29.25M28.12M
Deferred Income Tax(37.11M)(23.01M)(25.12M)(26.63M)80.77M
Stock-Based Compensation14.47M21.41M20.52M25.51M34.79M
Change in Working Capital66.71M106.06M106.49M157.18M96.28M
Accounts Receivables(24.98M)(66.92M)(48.28M)2.24M(106.22M)
Inventory00000
Accounts Payables1.87M6.43M1.05M(2.97M)2.63M
Other Working Capital89.82M166.54M153.72M157.9M199.86M
Other Non-Cash Items16.3M15.89M22.35M19.12M22.14M
Operating Cash Flow263.33M388.05M433.37M608.82M713.22M
Capital Expenditures(28.27M)(36.88M)(36.65M)(36.55M)(31.36M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.09M)(1.86M)2.02M8.24M216K
Investing Cash Flow(31.36M)(38.74M)(34.63M)(28.31M)(31.14M)
Debt Repayment050M(50M)00
Common Stock Issued000057M
Common Stock Repurchased(62.1M)(847.85M)(144.02M)(169.87M)(917.39M)
Dividends Paid00000
Other Financing Activities17.64M22.07M11.38M15.86M0
Financing Cash Flow(44.45M)(775.78M)(182.64M)(154.01M)(860.39M)
Effect of Forex Changes(3.97M)(6.57M)1.08M(2.51M)5.92M
Net Change in Cash183.54M(433.04M)217.18M423.99M(172.39M)
Free Cash Flow235.06M351.17M396.73M572.27M681.87M

Medpace Holdings, Inc.

NASDAQ:MEDP

Intrinsic Alpha fair value

Locked

Current Price

$646.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.